DeepLook Medical, a New Haven, CT-based firm specializing in visual enhancement technology for medical applications, secured an undisclosed amount in Series A funding.

Led by Xcellerant Ventures and OKG Capital, the funds will support commercializing DeepLook's technology, expanding into new modalities, and global outreach.

The company, under CEO Marissa Fayer, aims to revolutionize medical imaging with products like DL Precise™, which utilizes shape-recognition software for improved tumor morphology delineation, enhancing oncology diagnostics and treatment.

Additional efforts include integrating AI advancements to further enhance their patented technology, positioning DeepLook Medical as an innovator in medical imaging enhancement.